Search

everythinglearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Possible link between androgens and COVID-19 severity; more research needed.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Some drugs may help treat both COVID-19 and radiation injury.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Pharmacists play a crucial role in patient education and personalized care.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Ocrelizumab may cause total body hair loss in some patients.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

Covid-19 affected asthmatic patients in Western Saudi Arabia.

Possible link between COVID-19 and hair loss; more research needed.